A U.S. medical device manufacturer is operating in more than 40 international markets, including its most recent entries in the BRIC markets. The company president is now ready to look to new emerging markets for revenue growth. This time a more advanced “post-BRIC” analysis is needed to determine which market to enter next. Because the capital investment and risk associated with entering a new market is high, making the right market selection is critical.
看看哪些人也有訂購？